More articles from Immunology

IL33 Stimulates Innate Lymphoid Cells to Recruit CD8⁺ T Cells to PDACs
Cancer Discovery Apr 2020, 10 (4) 489; DOI: 10.1158/2159-8290.CD-RW2020-032
Rhabdoid Tumors Are Immunogenic and May Respond to Immunotherapy
Cancer Discovery Jan 2020, 10 (1) 13; DOI: 10.1158/2159-8290.CD-RW2019-171
NK Cells in the Tumor Microenvironment Have Fragmented Mitochondria
Cancer Discovery Dec 2019, 9 (12) OF6; DOI: 10.1158/2159-8290.CD-RW2019-165
PTPN2 Mediates Production of Exhausted T Cells and Antitumor Immunity
Cancer Discovery Nov 2019, 9 (11) OF5; DOI: 10.1158/2159-8290.CD-RW2019-151
Tregs Promote Protumor TAM Activity by Suppressing CD8+ T Cells
Cancer Discovery Sep 2019, 9 (9) 1155; DOI: 10.1158/2159-8290.CD-RW2019-120
TMEM176B Is a Potential Inflammasome-Associated Immune Checkpoint
Cancer Discovery Jul 2019, 9 (7) OF9; DOI: 10.1158/2159-8290.CD-RW2019-077
PD-L1/CD80 cis Interactions Disrupt PD-L1–PD-1 Binding and Promote T-cell Function
Cancer Discovery Jul 2019, 9 (7) OF10; DOI: 10.1158/2159-8290.CD-RW2019-075
Fatty Acid Transport Regulates Neutrophil Function in Tumors
Cancer Discovery Jun 2019, 9 (6) 692; DOI: 10.1158/2159-8290.CD-RW2019-064
DPP4 Inhibition Controls Tumor Growth via Eosinophil Recruitment
Cancer Discovery Apr 2019, 9 (4) 465; DOI: 10.1158/2159-8290.CD-RW2019-030
Antitumor PD-1⁻ CD8⁺ T-cell Subsets Expand upon Anti–PD-1/TIM3 Therapy
Cancer Discovery Mar 2019, 9 (3) 315; DOI: 10.1158/2159-8290.CD-RW2019-007

Main menu